Price Range (₹)
Price Range (₹)
Issue Size (₹ in Cr.)
Minimum Quantity
Bidding Period
In terms of a Technopak Report, the company is the second largest pharmacy retailer in India in terms of revenue from operations and number of stores, as of financial year 2021 (Source: Company RHP)
The company offers a wide range of products, including (i) pharmaceutical and wellness products such as medicines, vitamins, medical devices and test kits, and (ii) FMCG products such as home and personal care products, including toiletries, baby care products, soaps and detergents and sanitizers
India’s Second Largest Pharmacy retailer
Second largest pharmacy retailer in India, in terms of (i) revenue from operations for the financial year 2021, and (ii) number of stores as of March 31, 2021, according to the Technopak Report (Source: Company RHP).
Established Brand and Value Proposition to Customers
MedPlus” brand has a history and track record of over 15 years, and the company believes that it has become a well-established brand that has positioned to stand for genuine and good quality pharmaceutical products.
Lean Cost Structure and Technology Driven Operations
The company believes that their (i) scale of operations, (ii) wholly-managed and operated supply chain and distribution infrastructure, (iii) strong and integrated technology backbone, and (iv) focus on maintaining cost efficient operations gives an advantage over competitors.
The company will not receive any proceeds from the Offer for Sale.
The Selling Shareholders will receive the entire net proceedsfrom the Offer for Sale.
Failure to properly manage inventories and anticipate demand may impact financial performance
Subject to risks associated with consumer demand and changes in medical prescriptions. Also exposed to inventory risk in connection with products such as FMCG and private label products.
Pharmaceutical Supply Chain in India : The Indian domestic market consists of a large network of more than 500 medium and large companies (that manufacture/contract manufacture), ~60,000 distributors, and ~800,000 pharmacy retail outlets, with more than 100,000 pharmaceutical brands available in the market
Impact of the COVID-19 pandemic: The pandemic is driving growth in the market segments such as preventive healthcare and personal hygiene with consumers increasingly likely to purchase preventive healthcare products such as multivitamins and ayurvedic supplements to boost immunity. Personal hygiene products have also gained prominence. (Source: Company RHP).
Retail Individual Investor | |
Non-Institutional Investor | |
Qualified Institutional Buyers | |
Overall |
Applications
refunds
Convenient investments
of application
For ICICI Bank linked A/c
For non ICICI Bank A/c
Go to the IPO section, select the IPO you want to apply from the list and click on ‘Apply’.
Fill in the quantity of the number of shares you want to buy. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Click on proceed to confirm the order. You can view the placed order under “order book”.
Choose the IPO you want to apply from the list. Click on Apply.
Fill in the quantity of shares. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Check the A/C, UPI details and click on proceed. You will get an UPI link by which payment can be made.
Trusted by
customers
Investments & Liability Products
Investment Basket
Access to
Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.